Orchid Pharma Files FY 2025-26 Business Responsibility and Sustainability Report

Orchid Pharma Limited ( (IN:ORCHPHARMA) ) has issued an update. Orchid Pharma Limited, a Dhanuka Group company in the pharmaceutical sector, operates manufacturing facilities in Tamil Nadu and maintains a corporate office near Gurugram, reflecting a significant footprint in India's healthcare and capital markets. Listed on the National Stock Exchange of India and BSE, the company emphasizes regulatory compliance and transparency through regular investor communications. The company has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 with both major Indian stock exchanges, in line with Regulation 34 of SEBI's listing requirements. This report, which is integrated into Orchid Pharma's annual report and accessible on its website, underscores a growing focus on ESG transparency and may reinforce stakeholder trust and the firm's reputation as a responsible pharmaceutical player. More about Orchid Pharma Limited Orchid Pharma Limited, part of the Dhanuka Group, operates in the pharmaceutical industry with manufacturing facilities in Tamil Nadu and corporate offices in Gurugram, India. The company is listed on both the National Stock Exchange of India and BSE, reflecting its presence in the Indian capital markets and its focus on regulated disclosure and compliance. As a pharmaceutical player, Orchid Pharma serves domestic and international markets with formulations and related products, and is subject to the Securities and Exchange Board of India's listing and reporting requirements. Its investor-focused communications, including annual and sustainability-related reports, underscore an emphasis on transparency and corporate governance. Orchid Pharma has submitted its Business Responsibility and Sustainability Report for FY 2025-26 to Indian stock exchanges, aligning with Regulation 34 of SEBI's Listing Obligations and Disclosure Requirements. The report forms part of the company's annual report and is also available on its website for investors and stakeholders. By formally disclosing its business responsibility and sustainability practices, Orchid Pharma highlights its commitment to environmental, social and governance reporting, which may strengthen stakeholder confidence and support its positioning as a compliant and responsible pharmaceutical company in the Indian market. Average Trading Volume: 12,015 Technical Sentiment Signal: Strong Buy Current Market Cap: 48.42B INR For a thorough assessment of ORCHPHARMA stock, go to TipRanks' Stock Analysis page. This story was written using TipRanks's AI tools and reviewed by a TipRanks editor. Disclaimer & DisclosureReport an Issue